VIVAGEL Trademark

Trademark Overview


On Monday, May 2, 2016, a trademark application was filed for VIVAGEL with the United States Patent and Trademark Office. The USPTO has given the VIVAGEL trademark a serial number of 79197477. The federal status of this trademark filing is REGISTERED as of Tuesday, May 29, 2018. This trademark is owned by Starpharma Pty Limited. The VIVAGEL trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Pharmaceuticals, pharmaceutical preparations, and pharmaceutical drugs for medical purposes for prevention of viral and bacterial disease, namely, bacterial vaginosis, herpes simplex virus, human papilloma virus, and human immunodeficiency virus (HIV); chemical preparations for pharmaceutical and medical purposes for the prevention of bacterial vaginosis, herpes simplex virus, human papilloma virus and human immunodeficiency virus (HIV); chemical compounds in the nature of antimicrobial or ph balancing or microbial balancing substances all for medical purposes, namely, for treating and preventing vaginal microbial imbalance, vaginal pH imbalance, vaginal odor and discharge, bacterial vaginosis, viral STD, vaginaitis, vaginal thrush, vaginal disease symptom relief including itching, odor, and discharge, for maintaining a healthy balance of vaginal flora and for the reestablishment of the bacterial vaginal flora; polyvalent compounds and dendrimers sold as integral component parts of pha...

Contraceptive apparatus, namely, intravaginal cervical barriers; prophylactic instruments for use to prevent pregnancy and disease, namely, condoms, diaphragms, and intrauterine devices
vivagel

General Information


Serial Number79197477
Word MarkVIVAGEL
Filing DateMonday, May 2, 2016
Status700 - REGISTERED
Status DateTuesday, May 29, 2018
Registration Number5477567
Registration DateTuesday, May 29, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 13, 2018

Trademark Statements


Certificate of Correction for RegistrationIn the statement, Page 1, line 38, "FILED 10-27-2016" should be deleted, and "FILED 5-02-2016" should be inserted.
Goods and ServicesPharmaceuticals, pharmaceutical preparations, and pharmaceutical drugs for medical purposes for prevention of viral and bacterial disease, namely, bacterial vaginosis, herpes simplex virus, human papilloma virus, and human immunodeficiency virus (HIV); chemical preparations for pharmaceutical and medical purposes for the prevention of bacterial vaginosis, herpes simplex virus, human papilloma virus and human immunodeficiency virus (HIV); chemical compounds in the nature of antimicrobial or ph balancing or microbial balancing substances all for medical purposes, namely, for treating and preventing vaginal microbial imbalance, vaginal pH imbalance, vaginal odor and discharge, bacterial vaginosis, viral STD, vaginaitis, vaginal thrush, vaginal disease symptom relief including itching, odor, and discharge, for maintaining a healthy balance of vaginal flora and for the reestablishment of the bacterial vaginal flora; polyvalent compounds and dendrimers sold as integral component parts of pharmaceuticals preparations all for medical purposes for the treatment and prevention of bacterial vaginosis, herpes simplex virus, human papilloma virus, human immunodeficiency virus (HIV); antimicrobial preparations, namely, microbicidal preparations in the nature of gels, films, solutions, lubricants for vaginal and rectal use for prevention of bacterial vaginosis, herpes simplex virus, human papilloma virus, human immunodeficiency virus (HIV); chemical contraceptives, namely, sponges, gels, foams, creams, films, solutions, suspensions and lotions for use in preventing HIV and other sexually transmitted infections; prophylactic preparations for prevention of pregnancy and microbial disease of the reproductive system, namely, chemical contraceptives and antibacterial preparations in the nature of sponges, suppositories, sexual lubricants, gels, foams, creams, films, solutions, suspensions and lotions; pharmaceutical preparations in the nature of vaginal gels and lubricants all for the prevention of pregnancy and sexually transmitted infections and diseases of the human reproductive system
Pseudo MarkVIVA GEL
Translation of Words in MarkThe English translation of "VIVA" in the mark is "LIVE" or "LONG LIFE". The wording "VIVAGEL" has no meaning in a foreign language.
Goods and ServicesContraceptive apparatus, namely, intravaginal cervical barriers; prophylactic instruments for use to prevent pregnancy and disease, namely, condoms, diaphragms, and intrauterine devices

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 15, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, December 15, 2016
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameStarpharma Pty Ltd
Party Type30 - Original Registrant
Legal Entity Type82 - NOT AVAILABLE
AddressAU

Party NameStarpharma Pty Limited
Party Type20 - Owner at Publication
Legal Entity Type82 - NOT AVAILABLE
AddressAU

Party NameStarpharma Pty Limited
Party Type10 - Original Applicant
Legal Entity Type82 - NOT AVAILABLE
AddressAU

Trademark Events


Event DateEvent Description
Monday, May 29, 2023COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, June 7, 2019CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, April 26, 2019NEW REPRESENTATIVE AT IB RECEIVED
Saturday, December 8, 2018CORRECTION UNDER SECTION 7 ¿ PROCESSED
Tuesday, December 4, 2018CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Wednesday, November 28, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, October 30, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 30, 2018TEAS SECTION 7 REQUEST RECEIVED
Saturday, October 6, 2018FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, September 13, 2018FINAL DISPOSITION NOTICE SENT TO IB
Thursday, September 13, 2018FINAL DISPOSITION PROCESSED
Wednesday, August 29, 2018FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, May 29, 2018REGISTERED-PRINCIPAL REGISTER
Friday, March 16, 2018NOTIFICATION PROCESSED BY IB
Tuesday, March 13, 2018PUBLISHED FOR OPPOSITION
Wednesday, February 21, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 21, 2018NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 21, 2018NOTICE OF PUBLICATION
Tuesday, February 6, 2018EXPARTE APPEAL TERMINATED
Tuesday, February 6, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 6, 2018EXAMINERS AMENDMENT MAILED
Tuesday, February 6, 2018EXAMINER'S AMENDMENT ENTERED
Tuesday, February 6, 2018EXAMINERS AMENDMENT -WRITTEN
Tuesday, January 23, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 23, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, January 21, 2018TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, January 22, 2018EX PARTE APPEAL-INSTITUTED
Monday, January 22, 2018JURISDICTION RESTORED TO EXAMINING ATTORNEY
Monday, January 22, 2018EXPARTE APPEAL RECEIVED AT TTAB
Thursday, July 27, 2017NEW REPRESENTATIVE AT IB RECEIVED
Friday, July 21, 2017FINAL REFUSAL MAILED
Thursday, July 20, 2017FINAL REFUSAL WRITTEN
Friday, July 7, 2017PARTIAL INVALIDATION PROCESSED BY THE IB
Tuesday, June 27, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 27, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 23, 2017ASSIGNED TO LIE
Friday, June 9, 2017REFUSAL PROCESSED BY IB
Thursday, May 25, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 18, 2017NEW REPRESENTATIVE AT IB RECEIVED
Friday, April 28, 2017CORRECTION TRANSACTION RECEIVED FROM IB
Friday, February 10, 2017NEW REPRESENTATIVE AT IB RECEIVED
Thursday, February 9, 2017NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, February 9, 2017REFUSAL PROCESSED BY MPU
Thursday, February 9, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, February 8, 2017NON-FINAL ACTION WRITTEN
Monday, February 6, 2017ASSIGNED TO EXAMINER
Tuesday, December 20, 2016APPLICATION FILING RECEIPT MAILED
Friday, December 16, 2016NEW REPRESENTATIVE AT IB RECEIVED
Thursday, December 15, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 12, 2016LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, December 1, 2016SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB